期刊文献+

胃癌组织中HER-2蛋白的表达及其与临床病理参数的关系 被引量:1

Expression of HER-2 protein in gastric carcinoma and its relationship with clinicopathological parameters
下载PDF
导出
摘要 目的探讨胃癌患者HER-2的过表达及临床病理学意义。方法选取2013年1月至2014年6月在兰州大学第二医院收治的经病理确诊的胃癌患者共540例。IHC法检测胃腺癌患者中HER-2的表达,以改良Hercep Test评分标准进行HER-2免疫组化结果判读,用卡方检验分析HER-2蛋白在胃腺癌组织中的表达与临床病理学参数的相关性。结果540例患者平均年龄56.5岁,男女比例3.5:1。HER-2蛋白过表达(IHC3+)共88例,总过表达率为16.3%。胃癌患者HER-2蛋白的过表达与肿瘤发生部位、肿瘤分化程度、有无淋巴结转移、是否有神经血管侵犯有关(P<0.05),而与患者的性别、年龄、肿瘤大小、肿瘤浸润深度、TNM分期、有无远处转移无相关性(P>0.05)。结论胃癌患者HER-2蛋白总过表达率为16.3%。胃癌组织中HER-2蛋白的过表达与肿瘤发生部位、分化程度、有无淋巴结转移、是否有神经血管侵犯相关。 Objective To investigate the overexpression and clinicopathological significance of HER-2 in gastric cancer. Methods Altogether 540 cases of pathologically confirmed gastric cancer treated in second hospital of lanzhou university from January 2013 to June 2014 were studied. HER-2 expression status was evaluated by using immunohistochemistry and results were interpreted by the modified Hercep Test scoring standard.The association between HER-2 expression and clinicopathological parameters was analyzed by chi-square test.Results The average age was 56.5 and male to female ratio was 3.5:1. Overexpression of HER-2 protein(IHC3+) was found in 88 cases, accounted for 16.3%. HER-2 expression was not correlated with sex, age, tumor size,clinical stage, distant metastasis and the depth of invasion(all P>0.05). However, it was significantly correlated with the tumor location, degree of differentiation, lymph node metastasis and neural vascular invasion(P<0.05).Conclusion Overexpression rate of HER-2 was 16.3% in patients with gastric cancer. There was significantly positive association between HER-2 overexpression and tumor differentiation, location, lymph node metastasis and neural vascular invasion in gastric carcinoma.
出处 《消化肿瘤杂志(电子版)》 2017年第3期178-181,共4页 Journal of Digestive Oncology(Electronic Version)
基金 甘肃省胃肠病重点实验室开放课题(gswcky-2013-008)
关键词 胃癌 HER-2 免疫组织化学 临床病理参数 Gastric cancer HER-2 Immunohistochemistry Clinicopathological parameter
  • 相关文献

参考文献5

二级参考文献47

  • 1李慧,陈营.甘肃省1986年—1988年部分城乡居民恶性肿瘤死亡减寿年数及减寿率分析[J].中国肿瘤,1994,3(12):10-11. 被引量:3
  • 2李挺,黄枫,赵恭华,佟杰,王颖,解风丽.c-erbB一2癌基因产物在胃肿瘤的表达[J].中华病理学杂志,1994,23(4):239-240. 被引量:12
  • 3刘丰基,王元洪,王潍博.胃癌组织中Her-2/neu和E-cadherin的表达及临床意义[J].中华肿瘤防治杂志,2006,13(11):847-850. 被引量:7
  • 4Kamangar F,Dores GM,Anderson WF.Patterns of cancer incidence,mortality,and prevalence across five continents:defining priorities to reduce cancer disparities in different geographic regions of the world.J Clin Oncol,2006,24(14):2137-2150.
  • 5Akiyama T,sudo C,Oguwara H,et al.The product of the human c-erbB-2 gene:a 185-kilodalton glycoprotein with tyrosine kinase activity.Science,1986,232(4758):1644-1646.
  • 6Koeppen HK,wright BD,Burt AD,et al.Overexpression of HER2/neu in solid tumours:an immunohistochemical survey.Histopathology,2001,38(2):96-104.
  • 7Takehana T,Kunitomo K,Kono K,et al.Status of c-erbB-2 in gastric adenocareinoma:a comparative study of immunohistochemistry,fluorescence in situ hybridization and enzyme-linked immuno-sorbent assay.Int J Cancer,2002,98(6):833-837.
  • 8Sakai K,Moil S,Kawamoto T,et al.Expression of epidermal growth factor receptors on normal human gastric epitheha and gastric carcinomas.J Natl Cancer Inst,1986,77(5):1047-1052.
  • 9Fnjimoto-Ouchi K,Sckiguchi F,Yasnno H,et al.Antitumor activity of trastuzumab in combination with chemotherapy in human gastric cancer xenograft models.Cancer Chemother Phannacol,2007,59(6):795-805.
  • 10Yonemura Y,Ninomiya I,Yamaguchi A,et al.Evaluation of immunoreactidty for erbB-2 protein as a marker of poor short term prognosis in gastric cancer Cancer Res,1991,51(3):1034-1038.

共引文献82

同被引文献14

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部